about
Integrated disease management interventions for patients with chronic obstructive pulmonary diseaseClinical and economic impact of non-adherence in COPD: a systematic reviewCost effectiveness of guideline advice for children with asthma: a literature review.Effectiveness and cost-effectiveness of early assisted discharge for chronic obstructive pulmonary disease exacerbations: the design of a randomised controlled trial.Comparing methods of data synthesis: re-estimating parameters of an existing probabilistic cost-effectiveness model.The treatment of newly diagnosed patients with glaucoma or with ocular hypertension in The Netherlands: an observational study of costs and initial treatment success based on retrospective chart review.Resource use and costs of patients with glaucoma or ocular hypertension: a one-year study based on retrospective chart review in the Netherlands.RECODE: design and baseline results of a cluster randomized trial on cost-effectiveness of integrated COPD management in primary careLargely ignored: the impact of the threshold value for a QALY on the importance of a transferability factorWork status and productivity costs due to ankylosing spondylitis: comparison of three European countries.Costs of ankylosing spondylitis in three European countries: the patient's perspective.One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease.Early assisted discharge with generic community nursing for chronic obstructive pulmonary disease exacerbations: results of a randomised controlled trial.Exploring payment schemes used to promote integrated chronic care in Europe.The road not taken: transferability issues in multinational trials.A dynamic population model of disease progression in COPD.Economic analyses comparing tiotropium with ipratropium or salmeterol in UK patients with COPD.Crossing borders: factors affecting differences in cost-effectiveness of smoking cessation interventions between European countries.Patient preference and satisfaction in hospital-at-home and usual hospital care for COPD exacerbations: results of a randomised controlled trial.Short- and long-term efficacy of a community-based COPD management programme in less advanced COPD: a randomised controlled trial.A choice that matters? Smulation study on the impact of direct meta-analysis methods on health economic outcomes.Cost-effectiveness of early assisted discharge for COPD exacerbations in The Netherlands.Probabilistic Markov model to assess the cost-effectiveness of bronchodilator therapy in COPD patients in different countries.PRIORITIES FOR HEALTH ECONOMIC METHODOLOGICAL RESEARCH: RESULTS OF AN EXPERT CONSULTATION.The role of disease management programs in the health behavior of chronically ill patients.Are GOLD ABCD groups better associated with health status and costs than GOLD 1234 grades? A cross-sectional study.Developing and applying a stochastic dynamic population model for chronic obstructive pulmonary disease.Cost effectiveness of interventions for lateral epicondylitis: results from a randomised controlled trial in primary care.A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease.Is the EQ-5D responsive to recovery from a moderate COPD exacerbation?Influenza Vaccination in Children with AsthmaStrengthening the evidence-base of integrated care for people with multi-morbidity in Europe using Multi-Criteria Decision Analysis (MCDA)The Economic Effects of Screening for Obstructive Airway Disease: An Economic Analysis of the DIMCA ProgramThe cost diaryPatient utilities in chronic musculoskeletal pain: how useful is the standard gamble method?An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary RehabilitationBROADER ECONOMIC EVALUATION OF DISEASE MANAGEMENT PROGRAMS USING MULTI-CRITERIA DECISION ANALYSISReal-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapyTowards integrated care for chronic conditions: Dutch policy developments to overcome the (financial) barriersCost Consequences of Implementing an Electronic Decision Support System for Ordering Laboratory Tests in Primary Care: Evidence from a Controlled Prospective Study in The Netherlands
P50
Q24197521-DAF00C87-6783-4C7B-86D6-846B81CD6D0FQ26852247-1739B32F-49C8-477D-9365-6FE7838878DAQ30868889-BE144A9B-4AA7-446C-A548-98B12B627566Q33721432-201D4002-0804-45C8-A160-F00996D04E2AQ33766133-2919883F-B9FE-4021-AA5A-845B5AC7340AQ34005853-5608480F-8080-4104-B6F8-42C5757389A9Q34301418-E835C509-7059-47CE-9515-D27E9CADBE92Q34632774-F2EF875E-0469-42F2-BADC-80547A6C1710Q35178018-FD0CD968-01A5-4D20-8ADE-9811A698B62BQ35551561-CE5EA5B9-4500-491A-894C-5FA46FC681BCQ35552996-5ED91C1E-4D81-4A5F-90AF-60FA6ED9C45FQ35673686-C6390410-7DA3-49CE-B5F0-D75A487724DDQ36370339-E347B3C0-03C8-4DE9-AE58-DA183593A454Q38128423-47BD978A-A00F-4485-B694-544FD9F849ACQ38131747-4F612424-D71C-4E44-8406-895458EF058FQ40400871-945AEED8-3C5D-4F4E-8E54-E1CB16E8159AQ43186322-068E93F9-A7D2-4095-93AE-E9A57DF48E11Q43267003-3BBBB35E-6CDD-4F55-A175-6591755321A2Q43520205-401722C4-2FE7-485F-B71C-EFD1132E81C5Q43759510-755231F4-23DA-448B-84CC-A56361F20246Q44628538-F50FAB81-696E-4246-9048-772E52A1E12EQ46194444-22A6CF85-E005-450B-AA38-3D66EBCBB7D9Q46446855-74F0FE65-0093-44C3-A1C0-7B11D45AE773Q47635473-576896B2-63F9-44EB-964C-D8F9C6668013Q48090576-4570BE2B-27AC-4360-B236-7DA51CBEFF4BQ48092768-A4F423F1-0EEB-4579-B037-BF8ECB3F1DA7Q48524468-4A17E20F-2174-4DE2-942A-0D67800D1C40Q48554278-17FB2F5B-7EAE-44D7-8F0F-4061DBED1EA9Q51103821-F2169E36-36EB-47EF-8F74-57B34A0794A5Q53043834-5C75FA8E-F34F-411B-B1F2-340E012A73A1Q56880145-9ECC1633-2F98-4C6D-B984-1BBBD7204C76Q57174840-39A1BBD5-F0BC-457A-8B1C-B1B4D6647ADFQ57313709-6E8715B8-8772-47AA-AA36-E8D132CD9068Q58054658-3CA7AE1F-89F4-4550-B48A-44CBB5824CC9Q58054660-339C74E6-32E1-47CB-8F15-D8E8EF3F62ACQ60473179-41F1E037-4350-4DF0-A780-2CE8FF39BE36Q60473180-588DBEFC-206F-4BC7-BDAF-9ECDA63765FEQ60473182-BF88620D-0D0C-42C1-8355-CCBA2D3B1DFDQ60473184-399C251B-A5AD-46AF-A878-787E176AD404Q60473185-29E581B5-52DA-4EE5-A929-470E8993C895
P50
description
researcher, ORCID id # 0000-0001-8706-3159
@en
wetenschapper
@nl
name
Maureen Rutten-van Molken
@ast
Maureen Rutten-van Molken
@en
Maureen Rutten-van Molken
@es
Maureen Rutten-van Molken
@nl
type
label
Maureen Rutten-van Molken
@ast
Maureen Rutten-van Molken
@en
Maureen Rutten-van Molken
@es
Maureen Rutten-van Molken
@nl
prefLabel
Maureen Rutten-van Molken
@ast
Maureen Rutten-van Molken
@en
Maureen Rutten-van Molken
@es
Maureen Rutten-van Molken
@nl
P106
P21
P31
P496
0000-0001-8706-3159